Association of CRISPR-Cas System with the Antibiotic Resistance and Virulence Genes in Nosocomial Isolates of Enterococcus
Shuan Tao,Huimin Chen,Na Li,Yewei Fang,Yao Xu,Wei Liang
DOI: https://doi.org/10.2147/IDR.S388354
2022-11-30
Infection and Drug Resistance
Abstract:Shuan Tao, 1, 2 Huimin Chen, 1 Na Li, 3 Yewei Fang, 2 Yao Xu, 4 Wei Liang 2 1 School of Medicine, Jiangsu University, Zhenjiang, People's Republic of China; 2 Department of Clinical Laboratory, Ningbo First Hospital, Ningbo, People's Republic of China; 3 Bengbu Medical College, Bengbu, People's Republic of China; 4 School of Medicine, Ningbo University, Ningbo, People's Republic of China Correspondence: Wei Liang, Department of Clinical Laboratory, Ningbo First Hospital, No. 59. Liuting Road, Haishu District, Ningbo, ZheJiang, 315010, People's Republic of China, Tel +86 15351883016, Fax +86-051885213100, Email Purpose: This study aimed to investigate the prevalence of the CRISPR-Cas system in nosocomial isolates of Enterococcus and their possible association with antibiotic resistance and virulence genes. Materials and Methods: Identification and antimicrobial susceptibility of the microorganism were performed by the automatized VITEK 2 Compact system (bioMerieux, France). A total of 100 Enterococcus isolates were collected and identified by VITEK 2 Compact automatic microbial identification drug susceptibility analyzer. The prevalence of various CRISPR-Cas systems, antibiotic resistance genes and virulence genes were investigated by polymerase chain reaction (PCR). The prevalence of CRISPR-Cas systems associated with antibiotic resistance and virulence genes was performed by appropriate statistical tests. Results: A total of 100 isolates of Enterococcus were identified and there were 62/100(62.0%) Enterococcus faecalis isolates and 38/100(38.0%) Enterococcus faecalis isolates. In total, 46 (46.0%) of 100 isolates had at least one CRISPR-Cas locus. CRISPR elements were more prevalent in Enterococcus faecalis isolates. The results of PCR demonstrated that CRISPR1-Cas, orphan CRISPR2, and CRISPR3-Cas were present in 23 (23.0%), 42 (42.0%) and 5 (5.0%) Enterococcus isolates, respectively. Compared with CRISPR-Casnegative isolates, the CRISPR-Cas positive isolates showed significant lower resistance rates against ampicillin, erythromycin, levofloxacin, tetracycline, vancomycin, gentamicin, streptomycin, and rifampicin. Presumably consistent with drug susceptibility, fewer CRISPR loci were identified in vanA, tetM, ermB, aac6'-aph(2"), aadE , and ant(6) positive isolates. There was a significant negative correlation between the CRISPR-Cas locus and the enterococcal virulence factors enterococcal surface protein ( esp ) gene. Conclusion: In conclusion, the results indicated that the absence of the CRISPR-Cas system was negatively associated with some antibiotic resistance in clinical isolates of Enterococcus faecalis and Enterococcus faecium . Also, there was a negative correlation with the carriage of antibiotic resistance genes. Furthermore, CRISPR-Cas may prevent some isolates from acquiring certain virulence factors. Keywords: Enterococcus , CRISPR-Cas system, antimicrobial-antibiotic resistance gene, virulence genes Enterococci are a group of facultative anaerobic Gram-positive opportunistic pathogens. 1 Enterococcus faecium and Enterococcus faecalis are the dominant species of enterococci. 2 One of the most prominent features of enterococci is their high level of intrinsic and acquired resistance to many antibiotics. 3 Enterococci are inherently resistant to many first-line antimicrobial agents, such as clindamycin, cephalosporins, compound sulfonamide, and low-concentration aminoglycosides. 4,5 In addition, Enterococci can acquire antimicrobial resistance through horizontal genes transfer (HGT) mediated by mobile gene elements (MGEs) such as plasmids, phages, and transposons, which is one of the main mechanisms that contribute to the spread of resistance genes between bacteria. 6,7 Antibiotic resistance of enterococci and the ability to acquire and spread antibiotic resistance is a challenge in the clinical setting and increases the difficulty of treating enterococcal infectious diseases. 8 The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated (Cas) system is an acquired immune defense system with immune memory in prokaryotic genomes, which can effectively resist the acquisition of foreign mobile gene elements such as plasmids or phages to maintain the stability of bacterial genomes. 9,10 CRISPR-Cas system is one of the factors limiting the development and evolution of bacterial antibiotic resistance. 11 CRISPR-Cas is considered as a natural barrier to horizont -Abstract Truncated-
pharmacology & pharmacy,infectious diseases